KTTA - Pasithea Therapeutics Corp. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Pasithea Therapeutics Corp.
IPO Date: September 21, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $17.5M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.10 | 5.05%
Avg Daily Range (30 D): $0.02 | 3.38%
Avg Daily Range (90 D): $0.02 | 3.51%
Institutional Daily Volume
Avg Daily Volume: 1.35M
Avg Daily Volume (30 D): .18M
Avg Daily Volume (90 D): .47M
Trade Size
Avg Trade Size (Sh.): 289
Avg Trade Size (Sh.) (30 D): 371
Avg Trade Size (Sh.) (90 D): 380
Institutional Trades
Total Institutional Trades: 12
Avg Institutional Trade: $1.06M
Avg Institutional Trade (30 D): $.52M
Avg Institutional Trade (90 D): $.52M
Avg Institutional Trade Volume: .67M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: K
 
News
Jul 2, 2026 @ 2:41 PM
NOTICE TO DISREGARD -- Thea Foundation
Source: Unknown
Dec 2, 2025 @ 12:00 PM
Pasithea Therapeutics Announces Closing of $60 ...
Source: Patrick Gaynes
Nov 21, 2025 @ 5:35 PM
Pasithea Therapeutics Announces Positive PAS-004 T...
Source: Patrick Gaynes
May 15, 2025 @ 5:00 PM
Neurofibromatosis Type 1 Market Set to Witness Sig...
Source: Delveinsight
May 7, 2025 @ 9:00 PM
Pasithea Therapeutics Announces Closing of $5 M...
Source: N/A
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.59 $-.16 $-.12
Diluted EPS $-1.59 $-.16 $-.12
Revenue
Gross Profit
Net Income / Loss $-21.29M $-5.27M $-2.87M
Operating Income / Loss $-23.96M $-5.71M $-4.88M
Cost of Revenue
Net Cash Flow $48.35M $.01M $M
PE Ratio    
Splits
Jan 02, 2024 1:20